Literature DB >> 19770755

The renal vascular response to diabetes.

Pamela K Carmines1.   

Abstract

PURPOSE OF REVIEW: Diabetes mellitus is the primary cause of end-stage renal disease, yet the mechanisms underlying diabetic nephropathy remain ill-defined. The widely accepted opinion holds that events occurring early during the course of diabetes engender the eventual decline in renal function. This review will summarize recent advances (published January 2008 through June 2009) regarding the renal vascular and glomerular functional changes that occur during the early stage of diabetes. RECENT
FINDINGS: Reduced C-peptide levels and increased cyclooxygenase-2 activity both seem to promote diabetic hyperfiltration, presumably via effects on afferent arteriolar tone. In addition, exaggerated tonic influences of K+ channels on afferent arteriolar function likely act in concert with impaired Ca2+ influx responses to changes in membrane potential to promote vasodilation. Mechanisms underlying these changes remain largely speculative. Diabetes may also alter autoregulation of renal blood flow and glomerular filtration rate, as well as provoke afferent arteriolar dilation secondary to alterations in proximal tubular reabsorption; however, conflicting evidence continues to flood the literature concerning these events.
SUMMARY: New evidence has expanded our appreciation of the complexity of events that promote preglomerular vasodilation during the early stage of diabetes; however, it seems that the more we know, the less we understand.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19770755      PMCID: PMC2886724          DOI: 10.1097/MNH.0b013e32833240fc

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  48 in total

1.  Mechanisms for renal blood flow control early in diabetes as revealed by chronic flow measurement and transfer function analysis.

Authors:  Tracy D Bell; Gerald F DiBona; Ying Wang; Michael W Brands
Journal:  J Am Soc Nephrol       Date:  2006-06-28       Impact factor: 10.121

2.  Proinsulin C-peptide constricts glomerular afferent arterioles in diabetic mice. A potential renoprotective mechanism.

Authors:  Lina Nordquist; En Yin Lai; Mats Sjöquist; Andreas Patzak; A Erik G Persson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-12-12       Impact factor: 3.619

3.  Renal hemodynamic effect of cyclooxygenase 2 inhibition in young men and women with uncomplicated type 1 diabetes mellitus.

Authors:  David Z I Cherney; James W Scholey; Rania Nasrallah; Maria G Dekker; Cameron Slorach; Timothy J Bradley; Richard L Hébert; Etienne B Sochett; Judith A Miller
Journal:  Am J Physiol Renal Physiol       Date:  2008-04-09

4.  Potassium channel contributions to afferent arteriolar tone in normal and diabetic rat kidney.

Authors:  Carmen M Troncoso Brindeiro; Rachel W Fallet; Pascale H Lane; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2008-05-21

5.  In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes.

Authors:  Amanda J Edgley; Marianne Tare; Roger G Evans; Con Skordilis; Helena C Parkington
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-07-16       Impact factor: 3.619

6.  Intact renal afferent arteriolar autoregulatory responsiveness in db/db mice.

Authors:  Sungmi Park; Benjamin J Bivona; Yumei Feng; Eric Lazartigues; Lisa M Harrison-Bernard
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

7.  Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked.

Authors:  Tracy D Bell; Gerald F DiBona; Rachel Biemiller; Michael W Brands
Journal:  Am J Physiol Renal Physiol       Date:  2008-08-27

8.  Lack of A1 adenosine receptors augments diabetic hyperfiltration and glomerular injury.

Authors:  Robert Faulhaber-Walter; Limeng Chen; Mona Oppermann; Soo Mi Kim; Yuning Huang; Noriyuki Hiramatsu; Diane Mizel; Hiroshi Kajiyama; Patricia Zerfas; Josephine P Briggs; Jeffrey B Kopp; Jurgen Schnermann
Journal:  J Am Soc Nephrol       Date:  2008-02-06       Impact factor: 10.121

Review 9.  Role of C-Peptide in the regulation of microvascular blood flow.

Authors:  T Forst; T Kunt; B Wilhelm; M M Weber; A Pfützner
Journal:  Exp Diabetes Res       Date:  2008

Review 10.  C-Peptide effects on renal physiology and diabetes.

Authors:  L Rebsomen; A Khammar; D Raccah; M Tsimaratos
Journal:  Exp Diabetes Res       Date:  2008
View more
  25 in total

1.  Improvement of mild retinopathy in type 2 diabetic patients correlates with narrowing of retinal arterioles. A prospective observational study.

Authors:  Line Pedersen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-04-01       Impact factor: 3.117

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  The relationship of retinal vessel diameter to changes in diabetic nephropathy structural variables in patients with type 1 diabetes.

Authors:  R Klein; M D Knudtson; B E K Klein; B Zinman; R Gardiner; S Suissa; A R Sinaiko; S M Donnelly; P Goodyer; T Strand; M Mauer
Journal:  Diabetologia       Date:  2010-05-01       Impact factor: 10.122

4.  Inactivation of p66Shc Decreases Afferent Arteriolar KATP Channel Activity and Decreases Renal Damage in Diabetic Dahl SS Rats.

Authors:  Bradley S Miller; Shoshana R Blumenthal; Alexey Shalygin; Kevin D Wright; Alexander Staruschenko; John D Imig; Andrey Sorokin
Journal:  Diabetes       Date:  2018-08-21       Impact factor: 9.461

5.  Altered gap junctional communication and renal haemodynamics in Zucker fatty rat model of type 2 diabetes.

Authors:  T Takenaka; T Inoue; H Okada; Y Ohno; T Miyazaki; D J Chaston; C E Hill; H Suzuki
Journal:  Diabetologia       Date:  2011-05-15       Impact factor: 10.122

Review 6.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

Review 7.  Obesity, metabolic syndrome and diabetic nephropathy.

Authors:  Christine Maric; John E Hall
Journal:  Contrib Nephrol       Date:  2011-06-09       Impact factor: 1.580

8.  Diabetes modifies the role of prostanoids and potassium channels which regulate the hypereactivity of the rabbit renal artery to BNP.

Authors:  José M Centeno; Luis Miranda-Gómez; Mikahela A López-Morales; Teresa Jover-Mengual; María C Burguete; Vannina G Marrachelli; María Castelló-Ruiz; Alicia Aliena-Valero; Enrique Alborch; Francisco J Miranda
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-02-21       Impact factor: 3.000

Review 9.  Obesity and diabetic kidney disease.

Authors:  Christine Maric-Bilkan
Journal:  Med Clin North Am       Date:  2012-11-27       Impact factor: 5.456

10.  Angiotensin II contributes to glomerular hyperfiltration in diabetic rats independently of adenosine type I receptors.

Authors:  Daniela Patinha; Angelica Fasching; Dora Pinho; António Albino-Teixeira; Manuela Morato; Fredrik Palm
Journal:  Am J Physiol Renal Physiol       Date:  2013-01-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.